RA
PROF

Rosalind Advisors’s Profound Medical PROF Stock Holding History

Rosalind Advisors’s Portfolio PROF Stock Details PROF Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$5.51M Hold
828,118
– – 2.05% 14
2026
Q1 		$5.37M Sell
828,118
-240,837
-23% -$1.66M 2.16% 17
2025
Q4 		$8.41M Buy
1,068,955
+376,770
+54% +$2.42M 2.96% 16
2025
Q3 		$3.38M Hold
692,185
– – 1.16% 24
2025
Q2 		$4.08M Hold
692,185
– – 1.94% 19
2025
Q1 		$4.03M Hold
692,185
– – 1.96% 18
2024
Q4 		$5.2M Buy
692,185
+206,212
+42% +$1.58M 2.66% 15
2024
Q3 		$3.87M Sell
485,973
-47,360
-9% -$428K 2.48% 14
2024
Q2 		$4.47M Hold
533,333
– – 3.44% 12
2024
Q1 		$4.55M Hold
533,333
– – 4.25% 11
2023
Q4 		$4.53M Buy
+533,333
New +$5.07M 3.73% 14

Other funds holding PROF

Fidelity International
Fidelity International Hamilton, Bermuda $139B AUM 29.06% 1-Year Est. Return
GS
Gagnon Securities New York $519M AUM 44.91% 1-Year Est. Return
RA
Royce & Associates New York $12.4B AUM 64.17% 1-Year Est. Return
TIM
Timelo Investment Management Aurora, Ontario, Canada $349M AUM 28.06% 1-Year Est. Return
GA
Gagnon Advisors New York $157M AUM 36.77% 1-Year Est. Return
ZCP
Z3 Capital Partners Richmond, Virginia $476M AUM
LBA
Letko, Brosseau & Associates Montreal, Quebec, Canada $6.77B AUM 38.11% 1-Year Est. Return
MI
MMCAP International Grand Cayman, Cayman Islands $1.18B AUM 50.44% 1-Year Est. Return
AAP
Ardsley Advisory Partners Stamford, Connecticut $960M AUM 207.76% 1-Year Est. Return
RMC
Ring Mountain Capital Tiburon, California $238M AUM 61.63% 1-Year Est. Return

Rosalind Advisors's PROF Position: Q2 2026 in Review

Rosalind Advisors held its Profound Medical (PROF) position steady in Q2 2026 at 828,118 shares worth $5.51M. The position accounts for 2.05% of the portfolio, ranked #14.

Rosalind Advisors first reported a position in PROF in Q4 2023 and has held it in 11 quarters since. The position peaked at $8.41M in Q4 2025. 56 funds tracked by Wall St. Rank hold PROF as of Q2 2026.

  • Rosalind Advisors held 828,118 shares of Profound Medical worth $5.51M as of Q2 2026.
  • Rosalind Advisors left its Profound Medical share count unchanged in Q2 2026.
  • Profound Medical made up 2.05% of Rosalind Advisors's portfolio in Q2 2026, its #14 holding.
  • Rosalind Advisors first reported a position in Profound Medical in Q4 2023 and has held it in 11 quarters since.
  • Rosalind Advisors's Profound Medical position peaked at $8.41M in Q4 2025.
  • 56 funds tracked by Wall St. Rank held Profound Medical as of Q2 2026.

Based on Rosalind Advisors's 13F filing for Q2 2026, filed 14 Aug 2026.